CRY News and Press, CryoLife Inc. From 11/19/20

CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020 Webcast to Include Presentation by Steering Committee Co-Chair John H. Alexander, MD, MHS Highlighting Clinical Trial Progress PR Newswire ATLANTA, Nov. 19, 2020 ATLANT...

David Einhorn's 13F stock portfolio value increased from $922M to $1.22B this quarter. Greenlight added SYNNEX, NCR, Twitter, Intel, and Ingredion, while reducing AerCap Holdings. The short position in Tesla through puts was increased during the quarter. The largest three position...

David Einhorn's Greenlight Capital adds stakes CryoLife (CRY) with ~101K shares, Intel (INTC) with 300K shares, Twitter (TWTR) with ~488K shares, and Synnex (SNX) with 273K shares, according to its 13F filing for Q3.Exits Tempur Sealy International (TPX), Whirlpool (WHR), and Echostar (STAR)....

CryoLife, Inc. (CRY) Q3 2020 Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Lynn Lewis – Gilmartin Group Pat Mackin – Chief Executive Officer Ashley Lee – Chief Financial Officer Conference Call Participants Suraj Kalia – Oppenheimer Jeff...

CryoLife (CRY): Q3 Non-GAAP EPS of $0.13 beats by $0.17; GAAP EPS of -$0.08 beats by $0.01.Revenue of $65.13M (-4.1% Y/Y) beats by $5.89M.Press Release For further details see: CryoLife EPS beats by $0.17, beats on revenue

CryoLife Reports Third Quarter 2020 Financial Results PR Newswire ATLANTA, Nov. 4, 2020 ATLANTA , Nov. 4, 2020 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $65.1 million in the third qu...

CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results PR Newswire ATLANTA, Oct. 21, 2020 ATLANTA , Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company...

ATLANTA , Sept. 8, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Morgan Stanley Global Healthcare Conference. CryoLife's man...

CryoLife (NYSE: CRY ) acquires Florida-based  Ascyrus Medical for up to $200M, including $60M cash and $20M shares of CryoLife's common stock in upfront payment. More news on: CryoLife, Inc., Merger & acquisition news, Healthcare stocks news, Read more ...

ATLANTA , Sept. 2, 2020 /PRNewswire/ -- CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has acquired Ascyrus Medical LLC (Ascyrus).  Ascyrus is a Florida -based, privately-held developer of the...